Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis: a Prospective, Multicenter, Open-label, Non-inferiority, Randomised Controlled Trial(EROSION IV)

NCT07567625 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT07567625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07567625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis: a Prospective, Multicenter, Open-label, Non-inferiority, Randomised Controlled Trial(EROSION IV)
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
July 13, 2026
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), non-st-segment elevation myocardial infarction(nstemi), st-segment elevation myocardial infarction(stemi)